Over the changing healthcare technological landscape, Olive AI was introduced as an inspiring healthcare operations transformer by Artificial Intelligence. This organization was making a big promise to the medical facilities by utilizing AI-powered workflows to speed up their processes, cut expenses, and improve patient outcomes. Still, the company’s path was very volatile as it went from success to failure. Through this article, readers will know why Olive AI was once hailed as a game-changer. What kind of services does it provide? What technology was involved in the project? What are the takeaways for startups from the company’s journey?
Olive AI was an artificial intelligence company established in 2017 that specialized in automating complex and repetitive healthcare tasks. Olive AI was an innovative healthcare robotization company that utilized Artificial Intelligence (AI) and Machine Learning (ML) to remove the burden of administrative tasks from hospitals and healthcare organizations. Olive AI guarantees to increase revenue cycles, reduce costs, intensify patient care, and standardize the most important processes to revolutionize one of the most complicated sectors. It was a workflow Automation tool in the Healthcare industry.
Its powerful, scalable platform could take on a wide range of time-consuming tasks that often drain healthcare resources:
Olive AI provided a set of AI-enabled healthcare products that helped to minimize the expense, shorten the turnaround times, and elevate patient care. Its services were offered to the costliest and most inefficient areas in healthcare administration.
JAMA estimates that administrative costs comprise almost 25 % of the total costs in the USA hospital expenditures. Olive AI automates the processing of claims or insurance verification, along with patient registration. Cleveland Clinic achieved annual savings of about 1.2 million dollars and reduced manual labor hours after the implementation, which enabled the facility to transfer the funds to patient care and facility improvement.
Insurance claims have a 10- to 15-percent denial rate. Olive AI has nearly eliminated these losses through automating the claims processing, detecting income denial vulnerabilities pre-submission, and accelerating reimbursements. Its solutions also meant that hospitals can reduce their revenue collection cycles by 10 days on average. The adoption resulted in AdventHealth reducing its rate of claim denials by 30 percent.
Automating appointment scheduling, pre-registration, and Billing, Olive AI shortened the average scheduling time by 20 minutes. Baptist Health was able to reduce the wait time at the call centers, resulting in a forty percent increase in patient satisfaction and a faster response.
The annual claims denial costs U.S hospitals an equivalent of 262 billion dollars. Olive AI also discovered rejection patterns and proposed interventional plans to allow Mercy Health to reduce denial rates by 22 percent within the first year, resulting in the recovery of millions of dollars that would have been lost to revenue.
Medical billing errors are 80 percent of the cause of medical bill inaccuracy, holding up payments. Olive AI automated medical coding, charge capture, and claim submission, 25% fewer errors at Mount Sinai Health System, and accelerated and more accurate reimbursement.
There are errors in the documentation that cause expenditures of up to 11 billion annually. At Intermountain Healthcare, the use of Olive AI enhanced documentation accuracy by 15 percent within six months and reduced denials, resulting in higher reimbursement rates.
Olive AI’s platform was scalable for both small clinics and large hospital systems, supported by training resources. By 2021, it was active in 900+ hospitals across 40+ U.S. states, including 20+ of the top 100 health systems.
Through measurable cost savings, reduced denial rates, and better patient engagement, Olive AI transformed healthcare operations nationwide.
Olive AI also differed because it managed to integrate several sophisticated AI tools into a platform that would be suitable and adaptable across the whole range of healthcare. It is said that the company incorporated many foundational technologies:
Combining these technologies, Olive AI built a scalable automation platform capable of handling diverse, complex administrative processes across healthcare providers and payers. This enabled higher operational accuracy, shorter turnaround times, and redeployment of staff to more patient-focused tasks. Ultimately, Olive AI aimed to make healthcare smarter, faster, and more cost-efficient—signaling a new era of efficiency in one of the most challenging sectors.
In a world where healthcare struggles to keep up with demand, could one AI-powered company truly transform the system? Olive AI set out to prove it could, with Artificial Intelligence (AI) and Machine Learning (ML) at its side, reduce operations, optimize revenue cycles, cut administrative costs, and improve the patient experience.
Olive AI first entered the world during a moment of crisis itself, in the form of the COVID-19 pandemic, which was straining the limits of hospitals nationwide. Automation was not a desirable feature, but it was a necessity. With the promise of reduced delays, accelerated reimbursement, and better care, Olive AI was fast becoming a craze amongst healthcare providers as a digitized solution.
With the momentum of the digital health funding boom, Olive AI attracted the attention of the biggest investors. It has raised a record-breaking investment of $832 million by 2020. Its purple brand name soon became a common feature in more than 900 hospitals, networked in 40+ states (U.S.), including 20+ of the major 100 health systems.
Olive AI was even a representation of the future to many: a technologically advanced future where healthcare and technology were synergistic and collaborated to provide smarter, faster, and more humanized care. It was a movement, charting the possibilities of what could be done in healthcare innovation at a time when it was not a startup.
Metric | Details |
Deployment Scale | Over 600 hospitals in the U.S. are using Olive’s software |
Market Reach | Serving 22% of the top 100 U.S. health systems |
The software facilitates automation in high-volume patterns of administration, such as prior authorizations and insurance claims, supply stores, human resources, finance, accounting, and clinical administration departments.
Though it had a bright start and an innovative perspective, the collapse of Olive AI was preceded by the company suffering multiple critical and interrelated problems to such an extent that they eventually suffocated the company:
Combined, these difficulties pushed the company’s resources to the limit, eroded stakeholder trust, and reduced its competitiveness. Unable to solve these problems, Olive AI had to stop operations.
Olive AI is an example of the meteoric rise and dramatic crash of a real startup that can be used as a reference for big lessons in strategic deployment, execution, and adaptation in the market by future innovators.
In our hospital network, we rolled out the Olive AI claims automation, and within the first few weeks, we reduced manual errors and significantly accelerated reimbursement processes. But the migration with the legacy systems was slower than anticipated, which led to the temporary exigencies. As large as the promise was, we were urged not to invest further because we were seeing inconsistent ROI in the long term.” – Michael Chen, CFO, Metro Health Systems.
By automating prior authorizations through Olive AI, we achieved a significant reduction in approval times. It made the work processes of our pharmacists more efficient and enhanced patient satisfaction. Nevertheless, the implementation required significant customization of the system, and thus it was not fully implemented.” – Sophia Martinez, CareFirst Pharmacy Benefits Operations Manager.
Olive AI was a daring project to change healthcare through artificial intelligence, addressing industry pain points with revolutionary, simple solutions. Backed by strong investor support and real operational efficiency demand, it grew quickly—but its failure reflects the dangers of rapid expansion, merger challenges, and fierce competition in healthcare AI. Startups can learn from Olive AI that growth must be sustainable, value delivery clear, and adaptability essential for transforming healthcare and improving patient care.
Olive AI was a health technology company that used machine learning-powered automation to simplify the administrative processes in the healthcare field, such as claims management and prior authorization.
Sean Lane was the director of activities and the CEO of Olive AI.
Olive AI decided on the combination of three technologies, including robotic process automation (RPA), natural language processing (NLP), and machine learning (ML), to construct its platform for automating tasks.
Seven main reasons have been pinpointed for the failure of Olive AI: these are rapid overexpansion, integration complexities, market competition, delivery challenges, and a tightening venture capital environment.
There are many lessons that other startups can learn from Olive AI’s experience, such as focusing on sustainable growth, carefully handling the integration of healthcare, creating achievable expectations, and maintaining organizational agility.
Despite the lack of public information about Olive AI’s achieving profitability, it is reported that the company experienced rapid financial growth.
It is impractical for AI technologies to direct patient care. However, Olive AI’s initiatives aimed to increase the operational efficiency of healthcare organizations, consequently, in the long run, supporting better patient care.